EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents

Yexuan Wang iD, Junchao Chen, Yingchun He, Yinghua Lv, Haoyang Guo, Qingshan Zheng, Lujin Li

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16599 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Yexuan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Pediatric Obesity, Anti-Obesity Agents, Weight Loss. Die Arbeit nennt 52 Literaturangaben. Gefördert von: the National Key R&D Program of China, The National Natural Science Funds of China, Open Research Program of the State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study fills a gap in the current guidelines for paediatric obesity treatment by providing quantitative data and comparing the effectiveness of weight loss drugs in children and adolescents with that in adults. Researchers developed a pharmacodynamic model to evaluate the efficacy and influential factors of various weight loss drugs.

Method

A systematic search of public databases was performed to include randomized placebo‐controlled clinical studies on pharmacological treatment of obesity in children and adolescents. Efficacy characteristics of different weight‐loss medications and their influencing factors were characterized by constructing time‐course and covariate models, and performing subgroup analyses. These were then compared with efficacy models for adult patients to investigate differences in drug effectiveness between the two age groups.

Results

A comprehensive review of 31 articles involving 1723 participants from public databases was conducted. The analysis demonstrated that baseline Body Mass Index (BMI) significantly affected weight loss outcomes. To control for study variations, baseline BMI values were standardised to a median of 35.3 kg/m 2 , and placebo effects were removed to accurately determine drug efficacy. After these adjustments, mean weight reductions at 56 weeks (95% CI) were observed for semaglutide, phentermine‐topiramate (PT), sibutramine, probiotics, orlistat, metformin and GLP‐1 receptor agonists such as liraglutide, exenatide and dulaglutide, with losses of 12.55 (10.17–16.19), 10.16 (8.06–12.30), 5.86 (4.10–7.62), 3.23 (1.11–5.36), 2.66 (2.06–3.28), 2.29 (0.26–4.37), and 1.93 (1.17–2.72) kg, respectively. Drugs took 32.9–47.8 weeks to achieve their efficacy plateau, with GLP‐1 receptor agonists acting most rapidly. No significant differences in drug effectiveness were found between children/adolescents and adults for semaglutide, liraglutide, orlistat and high‐dose PT (15/92 mg). Notably, low‐dose PT (7.5/56 mg) was more effective in the paediatric population. Subgroup analyses indicated that GLP‐1 receptor agonists and orlistat were particularly effective in patients with non‐metabolic forms of obesity, and drugs were more efficacious in males.

Conclusions

This study provides key quantitative evidence to inform the use of weight‐loss medications in treating obesity in the paediatric demograph.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pediatric ObesityAnti-Obesity AgentsWeight LossHumansAdolescentChildTreatment OutcomeRandomized Controlled Trials as TopicBody Mass IndexMaleFemaleAdultOrlistat

Stichwörter der Autor:innen

dropout ratesdrug efficacymodel‐based meta‐analysisobesity in children and adolescentsweight loss drug

Substanzen

Anti-Obesity AgentsOrlistat

Autor:innen und Institutionen

  • Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine (Shanghai University of Traditional Chinese Medicine), Shanghai, China.

ORCID-Profile: Yexuan Wang

Förderung

  • the National Key R&D Program of China
  • The National Natural Science Funds of China
  • Open Research Program of the State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine

Zitieren

APA

Wang, Y., Chen, J., He, Y., Lv, Y., Guo, H., Zheng, Q., & Li, L. (2025). Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16599

Vancouver

Wang Y, Chen J, He Y, Lv Y, Guo H, Zheng Q, et al. Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16599

BibTeX
@article{Wang2025,
  author = {Wang, Yexuan and Chen, Junchao and He, Yingchun and Lv, Yinghua and Guo, Haoyang and Zheng, Qingshan and Li, Lujin},
  title = {Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16599}
}
Kostenlos starten →